- The Burrill Report

Osiris Wins Canadian Approval for World’s First Stem Cell Drug
Prochymal is only approved treatment for GvHD. Read More
A Venture Investor Cries Mea Culpa
The Burrill Report: May 21, 2012 Read More
Approvals of Innovative Drugs by FDA Surpass EU, Canada
Yale study challenges notion that the FDA lags behind its peers. Read More
Express Scripts Settles Employee Theft Charges
The weekly round-up of failed trials, missed targets, and other business mishaps. Read More
International Doctors' Group Criticizes Gates’ Global Vaccines Plan
Doctors Without Borders says strategy may fail to deliver. Read More
Agilent Acquires Dako for $2.2 Billion
Deal for Danish cancer diagnostic company is Agilent’s largest to date. Read More
Trial Seeks to Stop Alzheimer’s before it Starts
International collaboration undertakes expansive effort funded by NIH and industry. Read More
Kythera Files to Go Public Under JOBS Act
California company is the first biotech to take advantage of new law designed to make financing more accessible. Read More
Military Veterans Support Alternative Fuels
Retired generals warn Congress that national security is at risk. Read More
European Private Investment Fundraising Up 80 Percent
EVCA reports strong numbers despite economic turmoil in Europe. Read More

[Please login to post comments]